Safety and efficacy of sodium oligomannate in patients with Alzheimer’s disease: a systematic review and meta-analysis

Safety and efficacy of sodium oligomannate in patients with Alzheimer’s disease: a systematic review and meta-analysis

Abstract Background We aim to evaluate the efficacy and safety of a new marine oligosaccharide drug, sodium oligomannate (GV-971), developed in China to treat Alzheimer’s disease (AD). Methods We researched the following databases: Embase, Web of Science, PubMed, Cochrane library, and Scopus until S...

Full description

Bibliographic Details
Main Authors: Anas Zakarya Nourelden, Ibrahim Kamal, Abdelrahman G. Tawfik, Abdulrahman Ibrahim Hagrass, Ahmed Hashem Fathallah, Mohamed Sayed Zaazouee
Format: Article
Language:English
Published: SpringerOpen 2023-06-01
Series:The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Subjects:
Sodium oligomannate
GV-971
Alzheimer’s disease
Meta-analysis
Online Access:https://doi.org/10.1186/s41983-023-00682-y

Internet

https://doi.org/10.1186/s41983-023-00682-y

Similar Items